Airway inflammation in paper mill workers

Journal of Occupational and Environmental Medicine

Volumn 49, Issue 10, 2007, Pages 1135-1142

  Sikkeland, Liv I B ^a,b   Haug, Terje ^b   Stangeland, Astrid M ^a   Flatberg, Gøril ^a   Søstrand, Per ^b   Halvorsen, Bente ^a   Kongerud, Johny ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL COUNT; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HUMAN; HUMAN CELL; INDUSTRIAL WORKER; MACROPHAGE; NEUTROPHIL; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PAPER INDUSTRY; PARAMETER; RESPIRATORY TRACT INFECTION; SPUTUM ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 37349126271     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31814b2e87     Document Type: Article

References (24)

1. Vaisanen OM, Weber A, Bennasar A, Rainey FA, Busse HJ, Salkinoja-Salonen MS. Microbial communities of printing paper machines. J Appl Microbiol. 1998;84:1069-1084.
2. Ericsson J, Jarvholm B, Norin F. Respiratory symptoms and lung function following exposure in workers exposed to soft paper tissue dust. Int Arch Occup Environ Health. 1988;60:341-345.
3. Kraus T, Pfahlberg A, Gefeller O, Raithel HJ. Respiratory symptoms and diseases among workers in the soft tissue producing industry. Occup Environ Med. 2002;59:830-835.
4. Toren K, Sallsten G, Jarvholm B. Mortality from asthma, chronic obstructive pulmonary disease, respiratory system cancer, and stomach cancer among paper mill workers: a case-referent study. Am J Ind Med. 1991;19:729-737.
5. Rix BA, Lynge E. Industrial hygiene measurements in a new industry: the repulping and deinking of paper waste. Am J Ind Med. 1996;30:142-147.
6. Haug T, Sostrand P, Langard S. Exposure to culturable microorganisms in paper mills and presence of symptoms associated with infections. Am J Ind Med. 2002;41:498-505.
7. Douwes J, Versloot P, Hollander A, Heederik D, Doekes G. Influence of various dust sampling and extraction methods on the measurement of airborne endotoxin. Appl Environ Microbiol. 1995;61:1763-1769.
8. Alexis N, Soukup J, Ghio A, Becker S. Sputum phagocytes from healthy individuals are functional and activated: a flow cytometric comparison with cells in bronchoalveolar lavage and peripheral blood. Clin Immunol. 2000;97:21-32.
9. Llewellyn-Jones CG, Harris TA, Stockley RA. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med. 1996;153:616-621.
10. Sikkeland LIB, Kongerud J, Stangeland AM, Haug T, Alexis N. Macrophage enrichment from induced sputum. Thorax. 2007;62:558-559.
11. Douwes J, Thorne P, Pearce N, Heederik D. Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg. 2003;47:187-200.
12. Sigsgaard T, Jensen LD, Abell A, Wurtz H, Thomsen G. Endotoxins isolated from the air of a Danish paper mill and the relation to change in lung function: an 11-year follow-up. Am J Ind Med. 2004;46:327-332.
13. Eberl L, Tummler B. Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation. Int J Med Microbiol. 2004;294:123-131.
14. Barczyk A, Sozanska E, Trzaska M, Pierzchala W. Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids. Chest. 2004;126:389-393.
15. Kips JC, Inman MD, Jayaram L, et al. The use of induced sputum in clinical trials. Eur Respir J Suppl. 2002;37:47s-50s.
16. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22:672-688.
17. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 2004;4:617-629.
18. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003;28:12-24.
19. Sprong T, Stikkelbroeck N, van der LP, et al. Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J Leukoc Biol. 2001;70:283-288.
20. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001;13:85-94.
21. Hashimoto Si, Morohoshi K, Suzuki T, Matsushima K. Lipopolysaccharideinducible gene expression profile in human monocytes. Scand J Infect Dis. 2003;35:619-627.
22. Ma XT, Zhang XJ, Zhang B, et al. Expression and regulation of interleukin-23 subunits in human peripheral blood mononuclear cells and hematopoietic cell lines in response to various inducers. Cell Biol Int. 2004;28:689-697.
23. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest. 2006;116:1218-1222.
24. Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity. 2005;22:285-294.